Deep-learning technology could help scientists to develop personalized immunotherapies and vaccines

Deep-learning technology developed by a team of Johns Hopkins engineers and cancer researchers can accurately predict cancer-related protein fragments that may trigger an immune system response.

Q&A: Novo Nordisk Foundation’s Cellerator CEO Thomas Carlsen digs into $135.4M Danish cell therapy facility

The Novo Nordisk Foundation revealed Thursday it has committed €127 million ($135.4 million) to build a new cell therapy facility in Denmark, which is set

September 22, 2023

H1 2024 RESULTS – Major advances in all three programs – Several strategic agreements signed with the world medtech leader in cardiology – Extension of financial runway – Biotech Investments

EQS-News: Affluent Medical SA / Key word(s): Half Year Results Affluent Medical SA: H1 2024 RESULTS – Major advances in all three programs – Several

September 27, 2024

Computational tools unlock the secrets of the genome

In collaboration with the International Conference on Research in Computational Molecular Biology (RECOMB), Genome Research publishes a collection of 20 computational methods and their applications

October 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.